|
Volumn 52, Issue 4, 2005, Pages 151-158
|
Montelukast: new therapeutic option in patients with nasal polyps associated to respiratory allergic disease;Montelukast: nueva opción terapéutica en pacientes con poliposis nasal asociada a enfermedad alérgica respiratoria.
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETIC ACID DERIVATIVE;
BECLOMETASONE;
CYTOKINE;
EPHEDRINE;
INTERLEUKIN DERIVATIVE;
LEUKOTRIENE;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
LORATADINE;
MONTELUKAST;
QUINOLINE DERIVATIVE;
ADOLESCENT;
ADULT;
ARTICLE;
ASTHMA;
BLOOD;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG COMBINATION;
ENDOSCOPY;
EOSINOPHIL;
FEMALE;
FOLLOW UP;
HUMAN;
LEUKOCYTE COUNT;
MALE;
METABOLISM;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
NOSE POLYP;
RANDOMIZED CONTROLLED TRIAL;
ACETATES;
ADOLESCENT;
ADULT;
ASTHMA;
BECLOMETHASONE;
COMBINED MODALITY THERAPY;
CYTOKINES;
DRUG THERAPY, COMBINATION;
ENDOSCOPY;
EOSINOPHILS;
EPHEDRINE;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INTERLEUKINS;
LEUKOCYTE COUNT;
LEUKOTRIENE ANTAGONISTS;
LEUKOTRIENES;
LORATADINE;
MALE;
MIDDLE AGED;
NASAL POLYPS;
QUINOLINES;
|
EID: 32944481107
PISSN: None
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|